Raymond James Financial
INO icon

Raymond James Financial’s Inovio Pharmaceuticals INO Stock Holding History

Raymond James Financial’s Portfolio INO Stock Details INO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$46.5K Buy
42,286
+25,743
+156% +$30.5K ﹤0.01% 5267
2026
Q1 		$28.8K Sell
16,543
-145
-0.9% -$239 ﹤0.01% 5180
2025
Q4 		$29K Buy
16,688
+8
+0% +$18 ﹤0.01% 5059
2025
Q3 		$39K Buy
16,680
+16,309
+4,396% +$31.2K ﹤0.01% 4850
2025
Q2 		$755 Buy
+371
New +$711 ﹤0.01% 6613

Other funds holding INO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
BCM
Boxer Capital Management San Diego, California $1.33B AUM 864.5% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
EP
Eversept Partners New York $1.93B AUM 160.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Raymond James Financial's INO Position: Q2 2026 in Review

Raymond James Financial increased its Inovio Pharmaceuticals (INO) stake by 156% in Q2 2026, buying an estimated $30.5K and bringing the position to 42,286 shares worth $46.5K. The position accounts for ﹤0.01% of the portfolio, ranked #5267.

Raymond James Financial first reported a position in INO in Q2 2025 and has held it in 5 quarters since. 102 funds tracked by Wall St. Rank hold INO as of Q2 2026.

  • Raymond James Financial held 42,286 shares of Inovio Pharmaceuticals worth $46.5K as of Q2 2026.
  • Raymond James Financial bought 25,743 Inovio Pharmaceuticals shares in Q2 2026, an estimated $30.5K.
  • Inovio Pharmaceuticals made up ﹤0.01% of Raymond James Financial's portfolio in Q2 2026, its #5267 holding.
  • Raymond James Financial first reported a position in Inovio Pharmaceuticals in Q2 2025 and has held it in 5 quarters since.
  • 102 funds tracked by Wall St. Rank held Inovio Pharmaceuticals as of Q2 2026.

Based on Raymond James Financial's 13F filing for Q2 2026, filed 14 Aug 2026.